Global Cord Blood Corporation Files Annual Report on Form 20-F

Rhea-AI Summary

Global Cord Blood Corporation (NYSE: CO), China's leading provider of cord blood collection and related services, has filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. This report includes audited financial statements for the fiscal year ended March 31, 2021. Investors can access the Form 20-F on the SEC's website or the Investor Relations section of the Company's website.

GCBC remains the largest umbilical cord blood banking operator in China, offering comprehensive cord blood services.

Positive

• The Company filed its Annual Report on Form 20-F, providing transparency to investors.
• Includes audited financial statements, enhancing investor confidence.
• Maintains its position as the first and largest umbilical cord blood banking operator in China.

Negative

• None.

HONG KONG, July 29, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The filed Form 20-F includes audited financial statements for the fiscal year ended March 31, 2021. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov and also be found at the Investor Relations section of GCBC's website at http://ir.globalcordbloodcorp.com.

About Global Cord Blood Corporation

Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at:

http://www.globalcordbloodcorp.com. 

For more information, please contact:

Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com

ICR, Inc.

Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: William.zima@icrinc.com

View original content:https://www.prnewswire.com/news-releases/global-cord-blood-corporation-files-annual-report-on-form-20-f-301344162.html

SOURCE Global Cord Blood Corporation

FAQ

What does Global Cord Blood Corporation's Annual Report on Form 20-F include?

The Annual Report includes audited financial statements for the fiscal year ended March 31, 2021.

Where can I find the Annual Report of Global Cord Blood Corporation?

The Annual Report can be accessed on the U.S. Securities and Exchange Commission's website and in the Investor Relations section of the Company's website.

What is Global Cord Blood Corporation's stock symbol?

Global Cord Blood Corporation's stock symbol is CO.

When was the Annual Report filed by Global Cord Blood Corporation?

The Annual Report was filed on July 29, 2021.